MORGANTOWN, W.VA. – The WVU Medicine-WVU Hospitals Pharmacy has been recognized by the Anticoagulation Forum as an Anticoagulation Center of Excellence. This illustrates the Pharmacy’s strong commitment to providing the highest level of care to patients taking antithrombotic medications.
“We are proud to have passed the Anticoagulation Centers of Excellence assessment,” Todd Karpinski, Pharm.D., WVU Medicine chief pharmacy officer, said. “Only one in four pharmacies that apply for this designation receive Center of Excellence status. This designation demonstrates our continual dedication to meeting the highest standards of patient care and improving health outcomes.”
The Anticoagulation Centers of Excellence program offers a roadmap to consistent, sustainable excellence in five key areas of patient care. Because it successfully met the rigorous standards in each patient care pillar, the WVU Medicine Pharmacy will be considered an Anticoagulation Center of Excellence for three years. The program is led by Lisa Moherman, Pharm.D., and Rebekah Matuga, Pharm.D., in partnership with medical directors Marco Caccamo, D.O., and Carl Palmer, M.D.
“This program has given us the opportunity to assess our operations, streamline processes, improve transition of care and knowledge of drug therapy, and enhance patient education while learning more about disease state management,” Dr. Karpinski said. “It has given us a comprehensive standard that defines ideal practices for our anticoagulation service and a central place to find relevant resources for our practice.”